Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 82481 

medicine or osteopathy with a 

preventive medicine residency program. 

The PRCs conduct outcomes-oriented, 

applied prevention research, on priority 

public health topics using a multidisciplinary and community-engaged 

approach. Partners include, but are not 

limited to, state, local, and tribal health 

departments, departments of education, 

schools and school districts, 

community-based organizations, 

healthcare providers, and health 

organizations. Partners collaborate with 

the PRCs to assess community needs; 

identify research priorities; set research 

agendas; conduct research projects and 

related activities such as training and 

technical assistance; translate research 

findings; and disseminate research 

results to public health practitioners, 

other researchers, and the general 

public. 

In 2020, CDC convened a work group 

consisting of representatives from 11 

PRCs to review proposed data fields in 

PERS and provide feedback to CDC. 

Their feedback was used to refine the 

data fields and ensure feasibility of the 

data collection and reporting by PRCs. 

These data will be used for program 

monitoring and evaluation purposes. 

CDC’s proposed information 

collection plan is as follows: CDC will 

use the information reported by PRCs 

through PERS to identify training and 

technical assistance needs, respond to 

requests for information from Congress 

and other sources, monitor grantees’ 

compliance with cooperative agreement 

requirements, evaluate progress made in 

achieving goals and objectives, and 

inform program improvement efforts. In 

addition, these monitoring data will 

support CDC’s ability to describe the 

impact and effectiveness of the PRC 

Program. 

The CDC currently funds 26 PRCs and 

each center will annually report the 

required information to the CDC 

through PERS during years 3–5 of the 

cooperative agreement. The average, 

estimated annualized burden per 

respondent is 25 hours. The total, 

estimated, annualized burden for all 

respondents is 650 hours. The proposed 

web-based data collection system will 

allow data entry during the entire year, 

which will enable respondents to 

distribute burden throughout each 

funding year. Response burden is 

estimated to decrease significantly in 

years four and five, because cumulative 

reporting means some sections will 

require little to no editing through the 

funding cycle. The average estimated 

annualized burden for year three is 

expected to be 32 hours whereas the 

average estimated annualized burden for 

years four and five is expected to be 21 

hours. 

OMB approval is requested for three 

years, which will cover the last three 

years in the current funding cycle. As 

stated in the program announcement, 

PRC Program recipients are required to 

report data in PERS. There are no costs 

to respondents other than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondents Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

PRCs ................................................. PERS ............................................... 26 1 25 650 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2020–27819 Filed 12–17–20; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[CDC–2020–0123] 

Announcement and Request for 

comment on Non-Substantive Changes 

to Three Data Collections 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Request for comment. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC) in the 

Department of Health and Human 

Services (HHS) announces the opening 

of a public docket to obtain comment on 

non-substantive changes to three data 

collections conducted by CDC’s 

National Center for Health Statistics 

(NCHS). Although CDC has already 

obtained approval from the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act on these 

non-substantive changes, CDC is 

requesting public comment on these 

non-substantive changes. 

DATES: Electronic or written comments 

must be received by February 16, 2021. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2020– 

0123, by either of the following 

methods. 

Note: CDC does not accept comments by 

email. 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Jeffrey M. Zirger, Information 

Collection Review Office, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS–D74, Atlanta, 

Georgia 30329. 

Instructions: All submissions received 

must include the agency name, Docket 

Number, and the OMB number 

associated with the survey about which 

comments are being provided. CDC will 

post, without change, all relevant 

comments to Regulations.gov. 

Please note: Submit all comments 

through the Federal eRulemaking portal 

(regulations.gov) or by U.S. mail to the 

address listed above. Do not submit 

comments by email. 

FOR FURTHER INFORMATION CONTACT: 

Jeffrey M. Zirger, Information Collection 

Review Office, Centers for Disease 

Control and Prevention, 1600 Clifton 

Road, NE, MS–D74, Atlanta, Georgia 

30329; phone: 404–639–7570; Email: 

omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: With this 

notice, CDC is providing public notice 

regarding the addition of a small 

number of COVID–19 related questions 

to each of the following surveys 

National Ambulatory Medical Care 

Survey (NAMCS) OMB Control No. 

0920–0278, National Electronic Health 

Records Survey (NEHRS) OMB Control 

No. 0920–1015, and National Hospital 

Care Survey (NHCS) OMB Control No. 

0920–0212. These new questions are 

designed to provide information that is 

essential to CDC’s emergency response 

to the outbreak of a novel coronavirus. 

Because these three OMB numbers are 

associated with ongoing, long-term 

collections, OMB requires that public 

comments be solicited to inform any 

adjustments to the wording of the 

questions or modification of the specific 

content of the COVID–19 related 


khammond on DSKJM1Z7X2PROD with NOTICES
82482 Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 

questions in future rounds of data 

collections. 

National Ambulatory Medical Care 

Survey (NAMCS) (OMB Control No. 

0920–0278, Exp. 05/31/2022) 

NAMCS obtains nationally 

representative estimates on the 

provision of health care in physician 

offices and community health centers 

(CHCs). 

NAMCS added a short block of 

questions related to COVID–19 in both 

(1) the traditional office-based Physician 

Induction Interview, and (2) the 

Community Health Center (CHC) 

Director Induction Interview to provide 

essential information on how the 

pandemic affected care provided in 

office based physician offices and CHCs. 

The five questions (some with subquestions) added are presented below. 

No one respondent would answer all 

sub-questions. Since the interviewer has 

gained efficiency in the response 

options for the other non-COVID–19 

questions, the additional five questions 

will be absorbed by the current 

estimated burden calculations. 

Therefore, no change in burden is 

expected. 

NAMCS–1 Traditional Physician 

Induction Interview 

Now I would like to ask you a few 

questions about the coronavirus disease 

(COVID–19) and the impact it had on 

operations in your office and on your staff. 

During the past THREE months, how often 

did your office experience shortages of any 

of the following personal protective 

equipment due to the onset of the 

coronavirus disease (COVID–19) pandemic? 

Respirators or other approved facemasks 

Eye protection, isolation gowns, or gloves 

During the past THREE months, did your 

office have the ability to test patients for 

coronavirus disease (COVID–19) infection? 

During the past THREE months, how often 

did your office have a location where 

patients could be referred to for coronavirus 

disease (COVID–19) testing? 

During the past THREE months, did your 

office need to turn away or refer elsewhere 

any patients with confirmed or presumptive 

positive coronavirus disease (COVID–19) 

infection? 

During the past THREE months, did any of 

the following clinical care providers in your 

office test positive for coronavirus disease 

(COVID–19) infection? 

Physicians 

Physician assistants 

Nurse practitioners 

Certified nurse-midwives 

Registered nurses/licensed practical nurses 

Other clinical care providers 

During January and February 2020, was 

your office using telemedicine or telehealth 

technologies (for example, audio with video, 

web videoconference) to assess, diagnose, 

monitor, or treat patients? 

After February 2020, did your office’s use 

of telemedicine or telehealth technologies to 

conduct patient visits increase? 

After February 2020, how much has your 

office’s use of telemedicine or telehealth 

technologies to conduct patient visits 

increased? 

After February 2020, has your office started 

using telemedicine or telehealth 

technologies? 

Since your office started using these 

technologies, how many of your patient visits 

have been conducted using telemedicine or 

telehealth technologies? 

NAMCS–1 Community Health Center 

(CHC) Respondent Induction Interview 

Now I would like to ask you a few 

questions about the coronavirus disease 

(COVID–19) and the impact it had on 

operations in your CHC and on your staff. 

During the past THREE months, how often 

did your center experience shortages of any 

of the following personal protective 

equipment due to the onset of the 

coronavirus disease (COVID–19) pandemic? 

Respirators or other approved facemasks 

Eye protection, isolation gowns, or gloves 

During the past THREE months, did your 

center have the ability to test patients for 

coronavirus disease (COVID–19) infection? 

During the past THREE months, how often 

did your center experience shortages of 

coronavirus disease (COVID–19) tests for any 

patients who needed testing? 

During the past THREE months how often 

did your center have a location where 

patients could be referred to for coronavirus 

disease (COVID–19) testing? 

During the past THREE months, did your 

center need to turn away or refer elsewhere 

any patients with confirmed or presumptive 

positive coronavirus disease (COVID–19) 

infection? 

During the past THREE months, did any of 

the following clinical care providers in your 

center test positive for coronavirus disease 

(COVID–19) infection? 

Physicians 

Physician assistants 

Nurse practitioners 

Certified nurse-midwives 

Registered nurses/licensed practical nurses 

Other clinical care providers 

During January and February 2020, was 

your center using telemedicine or telehealth 

technologies (for example, audio with video, 

web videoconference) to assess, diagnose, 

monitor, or treat patients? 

After February 2020, did your center’s use 

of telemedicine or telehealth technologies to 

conduct patient visits increase? 

After February 2020, how much has your 

center’s use of telemedicine or telehealth 

technologies to conduct patient visits 

increased? 

After February 2020, has your center 

started using telemedicine or telehealth 

technologies? 

Since your center started using these 

technologies, how many of your patient visits 

have been conducted using telemedicine or 

telehealth technologies? 

National Electronic Health Records 

Survey (NEHRS) (OMB Control No. 

0920–1015, Exp. 12/31/2022) 

NEHRS collects information on officebased physicians’ adoption and use of 

electronic health record (EHR) systems, 

practice information, patient 

engagement, controlled substances 

prescribing practices, use of health 

information exchange (HIE), and the 

documentation and burden associated 

with medical record systems(which 

include both paper-based and EHR 

systems). 

Six telemedicine technology 

questions to assess the use of 

telemedicine to provide clinical services 

to patients in response to the COVID–19 

pandemic were added to NEHRS. The 

additional six questions will be 

absorbed by the current estimated 

burden calculations. Therefore, no 

change in burden is expected. 

NEHRS Questions 

Does your practice use telemedicine 

technology (e.g., audio, audio with video, 

web videoconference) for patient visits? 

1. Since January 2020, what percentage of 

your patient visits were through telemedicine 

technology? 

2. What type(s) of telemedicine tools did 

you use for patient visits? 

3. What, if any, issues affected your use of 

telemedicine? 

4. To what extent are you able to provide 

similar quality of care during telemedicine 

visits as you do during in-person visits? 

5. Please rate your overall satisfaction with 

using telemedicine technology for patient 

visits. 

6. Do you plan to continue using 

telemedicine visits (in addition to in-person 

visits) when appropriate once the COVID–19 

pandemic is over? 

National Hospital Care Survey (NHCS) 

(OMB Control No. 0920–0212, Exp. 03/ 

31/2022) 

NHCS collects information on 

inpatient hospital stays. The six 

questions related to COVID–19 were 

added to the NHCS Annual Hospital 

Interview were designed to provide 

insight into the impact of COVID–19 on 

the operations of hospital emergency 

departments (EDs) in the United States. 

These questions will ask about: (1) 

Shortages of COVID–19 tests, (2) 

creation of outside COVID–19 screening 

areas, (3) referrals for patients with 

confirmed or presumptive positive 

COVID–19 infection, (4) clinical care 

providers at the responding hospital 

testing positive for COVID–19, (5) the 

number of inpatient/emergency 

department ED visits for the year that 

were related to confirmed COVID–19, 

and (6) the number of inpatient/ED 

visits for the year that were related to 

presumptive positive COVID–19. The 

additional data collected from these 

questions only posed a minimal burden 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 244 / Friday, December 18, 2020 / Notices 82483 

on respondents; and was absorbed in 

the OMB burden previously approved. 

NHCS Questions: 

1. In the past year, did your hospital 

experience shortages of coronavirus disease 

(COVID–19) tests for any patients with 

presumptive positive COVID–19 infection? 

2. In the past year, did your hospital create 

areas outside the hospital entrance to screen 

patients for coronavirus disease (COVID–19) 

infection? 

3. In the past year, did your hospital need 

to turn away or refer elsewhere any patients 

with confirmed or presumptive positive 

coronavirus disease (COVID–19) infection? 

4. In the past year, did any of the following 

clinical care providers in your hospital test 

positive for coronavirus disease (COVID–19) 

infection? 

a. Physicians 

b. Physician assistants 

c. Nurse practitioners 

d. Certified nurse-midwives 

e. Registered nurses/licensed practical nurses 

f. Other clinical care providers 

5. For calendar year 2020, how many 

inpatient/ED visits at your hospital were 

related to CONFIRMED coronavirus disease 

(COVID–19) infections, by quarter or by year? 

Fill in the grid below. 

6. For calendar year 2020, how many 

inpatient/ED visits at your hospital were 

Confirmed COVID–19 visits and how many 

were Presumptive Positive COVID–19 visits 

by quarter or by year? 

Dated: December 14, 2020. 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2020–27820 Filed 12–17–20; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2020–0124] 

Advisory Committee on Immunization 

Practices (ACIP); Correction 

Notice is hereby given of a change in 

the meeting of the Advisory Committee 

on Immunization Practices (ACIP); 

December 18, 2020, 12:00 p.m.—6:00 

p.m., EST; and December 20, 2020, 

12:00 p.m.—6:00 p.m., EST (times 

subject to change, see the ACIP website 

for any updates: http://www.cdc.gov/ 

vaccines/acip/index.html), which was 

published in the Federal Register on 

December 11, 2020, Volume 85, Number 

239, page 80108. 

The meeting dates and times should 

read as follows: 

DATES: The meeting will be held on 

December 19—20, 2020 from 11 a.m. to 

4:30 p.m., EST (times subject to change, 

see the ACIP website for any updates: 

http://www.cdc.gov/vaccines/acip/ 

index.html). 

Written comments must be received 

on or before December 21, 2020. 

The meeting is open to the public. 

FOR FURTHER INFORMATION CONTACT: 

Stephanie Thomas, ACIP Committee 

Management Specialist, Centers for 

Disease Control and Prevention, 

National Center for Immunization and 

Respiratory Diseases, 1600 Clifton Road, 

NE, MS–H24–8, Atlanta, GA 30329– 

4027; Telephone: 404–639–8367; Email: 

ACIP@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2020–28090 Filed 12–16–20; 4:15 pm] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–10346] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 

(PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, and to allow 

a second opportunity for public 

comment on the notice. Interested 

persons are invited to send comments 

regarding the burden estimate or any 

other aspect of this collection of 

information, including the necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions, the accuracy of 

the estimated burden, ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and the use 

of automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

DATES: Comments on the collection(s) of 

information must be received by the 

OMB desk officer by January 19, 2021. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain . Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing.html. 

2. Call the Reports Clearance Office at 

(410) 786–1326. 

FOR FURTHER INFORMATION CONTACT: 

William Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: Under the 

Paperwork Reduction Act of 1995 (PRA) 

(44 U.S.C. 3501–3520), federal agencies 

must obtain approval from the Office of 

Management and Budget (OMB) for each 

collection of information they conduct 

or sponsor. The term ‘‘collection of 

information’’ is defined in 44 U.S.C. 

3502(3) and 5 CFR 1320.3(c) and 

includes agency requests or 

requirements that members of the public 

submit reports, keep records, or provide 

information to a third party. Section 

3506(c)(2)(A) of the PRA (44 U.S.C. 

3506(c)(2)(A)) requires federal agencies 

to publish a 30-day notice in the 

Federal Register concerning each 

proposed collection of information, 

including each proposed extension or 

reinstatement of an existing collection 

of information, before submitting the 

collection to OMB for approval. To 

comply with this requirement, CMS is 

publishing this notice that summarizes 

the following proposed collection(s) of 

information for public comment: 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection; Title of 

Information Collection: Appeals of 

Quality Bonus Payment Determinations; 


khammond on DSKJM1Z7X2PROD with NOTICES